According to market research report, "Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User - Global Forecast to 2023", The dental biomaterials market is projected to reach USD 9.6 billion by 2023 from an estimated USD 6.7 billion in 2018, at a CAGR of 7.4%. The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. 

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.

By application, the market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market.

The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198160556 

Based on the end user, the market is segmented into dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes.

In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.

Browse in-depth TOC on "Dental Biomaterials Market"

124 - Tables 
44 - Figures 
208 - Pages  

Get Free 10% Customization on this Report:  

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=198160556

The prominent players in the Dental Biomaterials Market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).